Samuel Álvarez-Almazán

4PUBLICATIONS
18CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsPharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 28, 2026
Four New Menadione Thioderivatives, Potential Antineoplastic Candidates: In Silico and PARP-1 Inhibition Studies.

Francisco Javier Pérez Flores, Luis Jaime Vázquez-López, Adriana Lizbeth Rivera Espejel

|Aug 26, 2023
Anti-Diabetic Activity of Glycyrrhetinic Acid Derivatives FC-114 and FC-122: Scale-Up, In Silico, In Vitro, and In Vivo Studies.

Samuel Álvarez-Almazán, Luz Cassandra Solís-Domínguez, Paulina Duperou-Luna

|Jan 10, 2022
In Vivo and Ex Vivo Evaluation of 1,3-Thiazolidine-2,4-Dione Derivatives as Euglycemic Agents.

Diana Alemán-González-Duhart, Samuel Álvarez-Almazán, Miguel Valdes

|Jan 12, 2020
Current molecular aspects in the development and treatment of diabetes.

Samuel Álvarez-Almazán, Jessica Georgina Filisola-Villaseñor, Diana Alemán-González-Duhart

Pageof 1